Trial By Error: More on the Mahana Therapeutics Deal

By David Tuller, DrPH As I wrote yesterday, Mahana Therapeutics has recently licensed from King’s College London an “innovative digital therapeutic”—a web-based program delivering a course of cognitive behavioral therapy to patients with irritable bowel syndrome. A page on the Mahana site promoting this web-delivered IBS-CBT program furthers the impression that this deal is steeped […]

Source link

Related posts

Trial By Error: A Bit More About Bristol’s Investigation


The human lymph node microenvironment unilaterally regulates T-cell activation and differentiation


IFReC, Osaka Univ.: Osaka University Immunology Frontier Research Center Postdoctoral Researcher


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy